| Name | Title | Contact Details |
|---|
Synergetics USA, Inc. (Synergetics USA) designs, manufactures and markets microsurgical instruments, medical capital equipment and other medical devices primarily for use in ophthalmic surgery and neurosurgical applications.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Milliman Care Guidelines is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Compass Professional Health Services is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Loomis House is a Holyoke, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.